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1036Objective: This study assessed the prophylactic effect of ventral cardiac denervation on reducing atrial fibrilla-
tion after coronary artery bypass grafting.
Methods: This randomized prospective study recruited 220 adult patients (aged 42–79 years) who were sched-
uled to undergo coronary artery bypass grafting. Of these patients, 110 underwent ventral cardiac denervation in
addition to coronary artery bypass grafting and 110 underwent only coronary artery bypass grafting. The demo-
graphic, intraoperative, and postoperative factors comprising atrial fibrillation were compared between the 2
groups. In addition, the predictive factors of atrial fibrillation in all 220 cases were assessed.
Results: The mean age and the distribution of gender, body mass index, diabetes mellitus, chronic obstructive
pulmonary disease, hypertension, hypercholesterolemia, and left main disease were not significantly different
between the 2 groups. Atrial fibrillation incidence was significantly different between the groups (P¼ .025),
with an incidence of 20.9% in the ventral cardiac denervation group and 10% in the control group. Atrial fibril-
lation occurred in 34 of the 220 patients, and ventral cardiac denervation was considered as a variable to evaluate
its possible role in the prevention of postoperative atrial fibrillation. Our multivariate analysis showed age
(P¼ .002; odds ratio, 1.098; confidence interval, 1.034–1.165) and ventral cardiac denervation (P¼ .044;
odds ratio, 2.32; confidence interval, 1022–5.298) as the predictive factors of atrial fibrillation after coronary ar-
tery bypass grafting.
Conclusions: Given the surprising results of the present study demonstrating that ventral cardiac denervation is
a predictive factor of atrial fibrillation after coronary artery bypass grafting, ventral cardiac denervation should not
be routinely considered for the prevention of atrial fibrillation after coronary artery bypass grafting. (J Thorac
Cardiovasc Surg 2010;140:1036-9)Atrial fibrillation (AF) has long been regarded as the most
common complication and supraventricular arrhythmia after
open surgeries, particularly coronary artery bypass grafting
(CABG). Its incidence in the wake of CABG was reported
to be within a wide range of 5% to 40%.1-5 In recent years,
several studies have focused on various pharmacologic and
operative approaches to prevent AF after cardiac surgery.
Ventral cardiac denervation (VCD) is one of these strategies;
however, there is controversy surrounding its effect on
reducing AF after cardiac surgery.3,4,6,7 In VCD, removal
of the nerves around the great vessels at the base of the heart
primarily reduces the effect of the autonomic tone on the
myocardium.4,7 This study evaluated the effectiveness of
this technique in reducing the incidence of AF after
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Study Population
This randomized prospective study, conducted from January 2007 to
December 2008, recruited 220 adult patients (age range, 42–79 years)
who were scheduled for CABG. The study was approved by the hospital
ethics committee, and written inform consent was preoperatively obtained
from the patients.
Patients with a history of cardiac surgeries and AF were excluded from
the study. A total of 220 patients were randomly divided into 2 groups
according to a computer-generated randomization table: A total of 110
patients underwent VCD in addition to CABG (group I), and 110 patients
underwent only CABG (control group¼ group II). All patients were on
a beta-blocker regimen preoperatively and postoperatively and underwent
on-pump CABG under mild hypothermia with crystalloid cardioplegia.
All operations were performed by the same surgeon at the Tehran Heart
Center.
The demographic, intraoperative, and postoperative factors comprising
AF were compared between the 2 groups. In addition, the predictive factors
of AF in all 220 cases were assessed.Definition of Study Variables
The preoperative variables comprised gender, history of diabetes, hyper-
tension, hypercholesterolemia, chronic obstructive pulmonary disease,
Canadian Cardiovascular Society classification (grades III and IV), latest
preoperative potassium (Kþ), and left main disease.
Cardiopulmonary bypass (CPB) and crossclamp times and the number of
grafts were the intraoperative variables. Postoperative AF, premature atrial
contraction, premature ventricular contraction, ventricular tachycardia, ven-
tricular fibrillation, and some major morbidities, including reoperation forgery c November 2010
FIGURE 1. Schematic view of VCD with removal of the adipose and al-
veolar tissues around the outer side of the great vessels of the heart. SVC,
Superior vena cava; PA, pulmonary artery.
Abbreviations and Acronyms
AF ¼ atrial fibrillation
CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
ECG ¼ electrocardiography
ICU ¼ intensive care unit
VCD ¼ ventral cardiac denervation
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Dbleeding, transient ischemic attack, stroke, pulmonary emboli, and heart
attack, were the postoperative variables assessed.
Definition of Hospital Stay Length
Number of days a patient stayed at the hospital after surgery. The defini-
tions of all the aforementioned variables are in accordance with our data
bank.8
Ventricular Cardiac Denervation
VCD was performed via the same technique described by Melo and
colleagues3 and Alex and Guvendik.4 The nerves around the great vessels
were removed at the base of the heart by removing the fat pads. Denervation
was commenced from the ascending aorta (supracoronary) by means of
removing the alveolar, nerve, and other surrounding tissues using electro-
cautery and was thereafter extended to the pulmonary artery and superior
vena cava (Figure 1). After VCD, all these 110 patients underwent CPB
and CABG in the same manner as the 110 control patients under mild
hypothermia with crystalloid cardioplegia.
Electrocardiography
All patients were closely monitored by continuous electrocardiography
(ECG) for at least 72 hours after surgery in the open heart intensive care
unit (ICU) and post-ICU before they were transferred to the open heart
ward at the discretion of the surgeon and anesthesiologist. In the ward,
12-lead ECG was performed routinely, also taking into account any symp-
toms and signs such as palpitation. In case of any episode of AF or other
arrhythmias, the patients were transferred to the post-ICU, where they
were once again kept under continuous ECG monitoring.
Statistical Analysis
The univariate analysis of the continuous variables was performed with
the Student t test, and the categoric variables were compared using the chi-
square test and Fisher’s exact test, as appropriate. The variables were in-
cluded in the multivariate logistic regression model if the P value was found
to be less than .15 in the univariate analysis. The association of the indepen-
dent predictors with AF in the final model was expressed as odds ratio with
95% confidence intervals. For the statistical analyses, SPSS version 13.0
(SPSS Inc, Chicago, IL) and SAS version 9.1 (SAS Institute Inc, Cary,
NC) were used. All P values were 2-tailed.RESULTS
Of the 220 patients who underwent CABG, 110 also un-
derwent VCD (case group) and the remaining 110 were the
control group. The mean age and the distribution of gender,
body mass index, diabetes mellitus, chronic obstructive pul-
monary disease, hypertension, hypercholesterolemia, and
left main disease were not significantly different between
the 2 groups. Table 1 shows the univariate analysis of theThe Journal of Thoracic and Carpreoperative, intraoperative, and postoperative variables be-
tween the groups. AF was significantly different between the
groups (P¼ .025), with an incidence of 20.9% in the VCD
group and 10% in the control group. The number of AF at-
tacks that occurred during the hospital stay and converted to
sinus rhythm with or without treatment was recorded in all
the patients. The first attack occurred 2.35 1.69 days and
1.71 1.25 days after the operation in the VCD and control
groups, respectively, which was not significantly different
(P¼ .370). Of the 23 patients with AF in the VCD group,
11 had 1 episode, 5 had 2 episodes, and 7 had 3 episodes
of AF attacks. Of the 11 patients with AF in the control
group, 8 had 1 episode, 2 had 2 episodes, and 1 had 3 epi-
sodes of AF attacks. Notably, none of the patients with AF
rhythm was discharged until the rhythm had returned to nor-
mal sinus rhythm.
AF occurred in 34 of 220 patients, and we considered
VCD as a variable to assess its potential role in the preven-
tion of postoperative AF. Our multivariable analysis sug-
gested age and VCD as factors affecting the occurrence of
AF after CABG in our study population (Tables 2 and 3).
We also recorded the incidences of repeated premature
atrial contraction, premature ventricular contraction, ventricu-
lar tachycardia, and ventricular fibrillation in the groups (Ta-
ble 1). The incidences of these arrhythmias were not
significantly different between the groups, although the inci-
dence was higher in the VCD group. Permanent pacemaker
implantation was not required in either of the groups.
The major morbidity rates, listed in Table 1, seemed to be
relevant to VCD and length of hospital stay. There was onlydiovascular Surgery c Volume 140, Number 5 1037
TABLE 1. Demographic and perioperative variables between the 2
groups*
Patient
characteristics
VCD group
n (%)
Control
group n (%) P value
Patient no. (n¼ 200) 110 110
Age (y) 63.47 7.80 62.18 7 .198
Male 89 (80.9%) 88 (80%) .865
Female 19 (19.1%) 22 (20%)
COPD 7 (6.4%) 8 (7.3%) .789
Diabetes mellitus 34 (30.9%) 29 (26.4%) .456
Hypercholesterolemia 55 (50%) 55 (50%) 1
Hypertension 50 (45.5%) 60 (54.5%) .178
CCS grades III and IV 54 (49.1%) 45 (41.3%) .246
Kþ (potassium) 4.38 0.37 4.42 0.44 .412
Left main disease 9 (8.9%) 7 (6.6%) .534
BMI 26.32 4.15 27.12 5.02 .203
CPB time (min) 66.62 13.61 60.91 16.44 .005
Crossclamp time (min) 38.74 8.42 36.63 17.35 .253
No. of grafts 3.86 0.77 3.27 0.77 <.001
LITA as arterial conduit 110 (100%) 109 (99.1%) 1
SVG 2.84 0.79 2.27 0.77 <.001
AF 23 (20.9%) 11 (10%) .025
PVC 16 (14.5%) 10 (9.1%) .210
PAC 14 (12.7%) 19 (17.3%) .345
VT/VF 1 (0.9%) 3 (2.7%) .372
Reoperation for bleeding 3 (2.7%) 3 (2.7%) 1
TIA/stroke 1 (0.9%) 1 (0.9%) 1
Pulmonary emboli 2 (1.8%) 0 .498
Heart block 0 0 -
Hospital stay 8.01 3.92 7.16 3.20 .081
30-d mortality 0 1 (0.9%) 1
VCD, Ventral cardiac denervation; COPD, chronic obstructive pulmonary disease;
CCS, Canadian Cardiovascular Society classification; BMI, body mass index; CPB,
cardiopulmonary bypass; LITA, left internal thoracic artery; SVG, saphenous vein
grafting; AF, atrial fibrillation; PAC, premature atrial contraction; PVC, premature
ventricular contraction; VT, ventricular tachycardia; VF, ventricular fibrillation; TIA,
transient ischemic attack. *Data are presented as mean  standard deviation.
TABLE 2. Univariate analysis of predictive factors of atrial
fibrillation after coronary artery bypass grafting*
Patient characteristics AF, n (%) No AF, n (%) P value
Patient no. 34 (15.5%) 186 (84.5%)
Age (y) 66.59 6.69 62.14 7.36 .001
Male 25 (79.4%) 150 (80.6%) .868
Female 7 (20.6%) 36 (19.4%)
COPD 1 (2.9%) 14 (7.5%) .477
Diabetes mellitus 8 (23.5%) 55 (29.6%) .474
Hypercholesterolemia 16 (47.1%) 94 (50.5%) .709
Hypertension 21 (61.8%) 89 (47.8%) .136
CCS grades III and IV 20 (60.6%) 79 (42.5%) .054
Kþ (potassium) 4.49 0.42 4.38 0.40 .187
Left main disease 2 (6.5%) 14 (8%) 1
BMI 27.14 4.66 26.66 4.63 .588
CPB time (min) 66.32 16.31 63.30 14.94 .286
Crossclamp time (min) 38.26 9.23 37.58 14.33 .787
No. of grafts 3.67 1 3.54 0.79 .411
LITA graft as
arterial conduit
34 (100%) 185 (99.5%) 1
SVG 2.67 1 2.52 0.79 .338
VCD 23 (67.6%) 87 (46.8%) .025
AF, Atrial fibrillation; COPD, chronic obstructive pulmonary disease; CCS, Canadian
Cardiovascular Society; BMI, body mass index; CPB, cardiopulmonary bypass; LITA,
left internal thoracic artery; SVG, saphenous vein graft;VCD, ventral cardiac denervation.
*Data are presented as n (%) for categoric variables and mean standard deviation for
numeric variables.
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the result of ventricular fibrillation and cardiac arrest.TABLE 3. Predictors of atrial fibrillation after coronary artery bypass
grafting: Results of multivariate analysis
Patient
characteristics P value Odds ratio
95% confidence
interval
Age .002 1.098 1.034–1.165
VCD .044 2.32 1.022–5.298
VCD, Ventral cardiac denervation. Hosmer–Lemeshow goodness-of-fit test; chi-
square¼ 7.5941, df¼ 8, P¼ .4741, area under the receiver operating characteristic
curve; c¼ 0.74652.DISCUSSION
VCD was first described in 1936 by Arnulff9 and was
used for the prevention of coronary spasm several years
later.6 Currently, it is deemed as a safe and fast method for
reducing the fluctuating autonomic tone and, subsequently,
postoperative AF by cutting the autonomic nerves around
the great vessels in the base of the heart without prolonging
the operation time.3,4 However, there is still some contro-
versy in the literature over the efficacy of this method in
blunting post-CABGAF.3,4,6 In a large nonrandomized pop-
ulation study,Melo and colleagues3 reported a significant re-
duction in the incidence of AF after CABG from 27% in the
control group to 7% in the VCD group. Nonetheless, this
sufficient effect of VCD seems to be affected by the telem-
etry monitoring of only 15% of the patients during hospital-
ization and performing the VCD procedure by different1038 The Journal of Thoracic and Cardiovascular Sursurgeons.3 In contrast to Melo and colleagues’ study, some
recent studies have shown lower or no efficacy of VCD in
reducing post-CABG AF.4,6 Alex and Guvendik4 reported
no significant effect of VCD in decreasing the incidence
rate of post-CABG AF (29% in the case group vs 34% in
the control group). In 2004, Cummings and colleagues7 sug-
gested that the removal of the adipose tissue during denerva-
tion might even increase the incidence of AF after CABG
(37% in the case group vs 7% in the control group). In
2008, Breda and colleagues6 demonstrated the adverse
effect of VCD on post-CABG AF (12% in the VCD group
vs 8% in the control group). In our study, AF was signifi-
cantly higher in the VCD group (20.9% vs10%), which
is in agreement with recent studies.4,6,7 Our finding was
confirmed by the multivariate regression analysis for pre-
dicting post-CABG AF, which highlighted age and VCD
as the predictive factors of postoperative AF, which may
be due to such factors as close monitoring of the patients,
recording any paroxysmal AF rhythm, or performinggery c November 2010
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founding factors such as demographic variables and length
of hospital stay were not significantly different between the
groups. CPB time was significantly different between the
groups in the univariate analysis and lasted approximately
5 to 7 minutes; thus, CPB time does not seem to be clini-
cally effective in the occurrence of postoperative AF. Fur-
thermore, the multivariate regression analysis did not
predict CPB time as an independent factor for post-
CABG AF (Table 3).
Some intractable arrhythmias, such as premature atrial
contraction, ventricular tachycardia, and ventricular fibrilla-
tion, were not significantly different between the groups. On
the other hand, the incidence of repeated premature ventric-
ular contraction was more common in the VCD group,
although it was not significantly different. AF and premature
ventricular contraction might occur after destruction of the
nerves and disturbance of the autonomic nervation balance
and blood supply to the sinoatrial node, and there is higher
rate of eradication of the parasympathetic fibers compared
with the sympathetic fibers. Further studies are required to
corroborate this.
In the present study, all patients were receiving beta-
blockers as premedication, which was continued postopera-
tively. Diabetic patients were enrolled in the study, and our
analysis showed the same distribution of these patients into
the 2 groups with a postoperative AF occurrence of 11.8%
in the diabetic patients of the VCD group (4/34) and
13.8% in the diabetic patients of the control group. It seems
that the bias noted by Alex and Guvendik4 regarding the
effect of diabetes mellitus and beta-blockers on VCDs did
not confound the study.Study Limitations
When the patients were transferred from the ICU to the
open heart ward (as decided by the surgeon and anesthesi-
ologist) after at least 72 hours of close monitoring by con-The Journal of Thoracic and Cartinuous ECG, only 12-lead ECG was provided, which is
also routine in case of any symptoms and signs such as pal-
pitation. Afterward, if any of the patients experienced any
episode of AF or other arrhythmias, they were transferred
to the post-ICU, where continuous ECG was once again
provided. Had all the patients been closely monitored at
all times, the rate of recorded AF may have increased.CONCLUSIONS
In light of these results and the increasing chance of
post-VCD adhesion, which renders redo surgery difficult,
VCD should not be routinely practiced to prevent post-
CABG AF until further studies have clarified its effect on
postoperative AF.References
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